Heterogeneity in Methods of Estimating Kidney Function for Cancer Clinical Trial Eligibility
This cross-sectional study examined the kidney-function eligibility criteria for patients for enrollment in contemporary cancer clinical trials.
Authors
- Matthew H. Abramson (ORCID: https://orcid.org/0000-0002-7805-2287)
- Rodrigo Paredes (ORCID: https://orcid.org/0000-0003-2886-9763)
- Matthew D. Galsky (ORCID: https://orcid.org/0000-0001-7655-9378)
- Alexander B. Karol (ORCID: https://orcid.org/0000-0001-8277-9932)
- Himanshu Joshi (ORCID: https://orcid.org/0000-0003-0272-0733)
- Anna Argulian
- Yu Fujiwara (ORCID: https://orcid.org/0000-0003-1406-2352)
Institutions
- Mount Sinai Beth Israel (US)
- Roswell Park Comprehensive Cancer Center (US)
- Mount Sinai Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.33387
- Citations
- 1
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42